FDA Issues Draft Guidance For Development Of Generic Anti-Abuse Opioids

The FDA has released a draft guidance on creating generic versions of anti-abuse opioid drugs. This move is part of the agency's overall strategy to stop abuse and misuse of the substance by boosting abuse-deterrent opioid technologies.